Citation Impact
Citing Papers
Histone Deacetylase Inhibitor Panobinostat Induces Clinical Responses with Associated Alterations in Gene Expression Profiles in Cutaneous T-Cell Lymphoma
2008
Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 Axis
2009 Standout
Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: A double-blind, randomized, vehicle-controlled study*
2002
Sensitivity and specificity of reflectance-mode confocal microscopy for in vivo diagnosis of basal cell carcinoma: A multicenter study
2004
Basal cell carcinomas: attack of the hedgehog
2008 Standout
A clinical study comparing methyl aminolevulinate photodynamic therapy and surgery in small superficial basal cell carcinoma (8–20 mm), with a 12‐month follow‐up.
2008
Superficial, Nodular, and Morpheiform Basal-Cell Carcinomas Exhibit Distinct Gene Expression Profiles
2008
A systematic review of worldwide incidence of nonmelanoma skin cancer
2012 Standout
Confocal Imaging–Guided Laser Ablation of Basal Cell Carcinomas: An Ex Vivo Study
2014 Standout
Basal Cell Carcinomas and Actinic Keratoses Seen in Dermatological Practice in France: A Cross-Sectional Survey
2008
Increase in basal cell carcinoma incidence steepest in individuals with high socioeconomic status: results of a cancer registry study in the Netherlands
2009
The Effect of Skin Examination Surveys on the Incidence of Basal Cell Carcinoma in a Queensland Community Sample: A 10-Year Longitudinal Study
2004
EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome
2006
Guidelines on the use of therapeutic apheresis in clinical practice—Evidence‐based approach from the apheresis applications committee of the American Society for Apheresis
2010
Natural products: An evolving role in future drug discovery
2011 Standout
A Pilot Trial of Rituximab in the Treatment of Patients With Dermatomyositis
2007
Interleukin-10-Producing Plasmablasts Exert Regulatory Function in Autoimmune Inflammation
2014 StandoutNobel
Clinical development and potential of photothermal and photodynamic therapies for cancer
2020 Standout
Descriptive epidemiology of basal cell carcinoma and cutaneous squamous cell carcinoma in Soria (north‐eastern Spain) 1998–2000: a hospital‐based survey
2004
Role of AID in Tumorigenesis
2007 StandoutNobel
The safety and side effects of monoclonal antibodies
2010
Mycosis Fungoides and Sezary Syndrome
2017
WHO-EORTC classification for cutaneous lymphomas
2005 Standout
Sézary syndrome: Immunopathogenesis, literature review of therapeutic options, and recommendations for therapy by the United States Cutaneous Lymphoma Consortium (USCLC)
2010
The spectrum of cutaneous T-cell lymphomas: new insights into biology and therapy
2005
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
Plasmonic photothermal therapy (PPTT) using gold nanoparticles
2007 Standout
Pyroptosis: mechanisms and diseases
2021 Standout
Drug repurposing: progress, challenges and recommendations
2018 Standout
Inhibition of the Hedgehog Pathway in Advanced Basal-Cell Carcinoma
2009 Standout
European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 2017
2017
Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes
2012
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Aggressive basal cell carcinoma: Presentation, pathogenesis, and management
2004
Photodynamic therapy of cancer: An update
2011 Standout
Repertoire Enhancement with Adoptively Transferred Female Lymphocytes Controls the Growth of Pre-Implanted Murine Prostate Cancer
2012 StandoutNobel
Plant-derived immunomodulators: an insight on their preclinical evaluation and clinical trials
2015 Standout
Monoclonal Antibodies in the Treatment of Non-Hodgkin???s Lymphoma
2007
The AID Dilemma
2012 StandoutNobel
Development of therapeutic antibodies for the treatment of diseases
2020 Standout
Treatment of severe pemphigus with protein A immunoadsorption, rituximab and intravenous immunoglobulins
2007
Gold nanoparticles in biomedical applications: recent advances and perspectives
2011 Standout
The Clavien-Dindo Classification of Surgical Complications
2009 Standout
Cutaneous Dermatomyositis: An Updated Review of Treatment Options and Internal Associations
2013
Extracorporeal photochemotherapy in mycosis fungoides
2017
Guidelines on the use of therapeutic apheresis in clinical practice—Evidence‐based approach from the apheresis applications committee of the American society for apheresis
2007
Mycosis fungoides and the Sézary syndrome
2004
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Primary Cutaneous B-Cell Lymphoma Treated With Radiotherapy: A Comparison of the European Organization for Research and Treatment of Cancer and the WHO Classification Systems
2004
Phase II Multi-Institutional Trial of the Histone Deacetylase Inhibitor Romidepsin As Monotherapy for Patients With Cutaneous T-Cell Lymphoma
2009 Standout
Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL)
2006 Standout
Inflammatory Muscle Diseases
2015 Standout
Current concepts in the diagnosis and management of cytokine release syndrome
2014 Standout
Distinct types of primary cutaneous large B-cell lymphoma identified by gene expression profiling
2004
Graft-versus-leukemia effects of transplantation and donor lymphocytes
2008
Chemical Proteomics Reveals Ferrochelatase as a Common Off-target of Kinase Inhibitors
2016
An assessment of treatment history and its association with clinical outcomes and relapse in 155 pemphigus patients with response to a single cycle of rituximab
2014
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice—Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Sixth Special Issue
2013
Results of conservative treatment for perforated gastroduodenal ulcers in patients not eligible for surgical repair
2007
A review of the current use of rituximab in autoimmune diseases
2008
Interventions for pemphigus vulgaris and pemphigus foliaceus
2009
Tumour ablation by laser in general surgery
1990
CutaneousT ‐cell lymphoma: 2016 update on diagnosis, risk‐stratification, and management
2015
A retrospective comparative outcome analysis following systemic therapy in M ycosis fungoides and S ezary syndrome
2016
How I treat mycosis fungoides and Sézary syndrome
2016
Hematological Problems in Pediatric Intensive Care
2013 Standout
Melanoma
2019
Systemic therapy for cutaneous T-cell lymphoma: who, when, what, and why?
2016
The role of extracorporeal photopheresis in the management of cutaneous T‐cell lymphoma, graft‐versus‐host disease and organ transplant rejection: a consensus statement update from the UK Photopheresis Society
2017
Works of Christopher McCormack being referenced
Differences in age and body site distribution of the histological subtypes of basal cell carcinoma. A possible indicator of differing causes.
1997
Mechanisms of carbon dioxide laser reduction of tumor recurrence in experimental mammary tumor
1987
Changing trends in the incidence of invasive melanoma in Victoria, 1985–2015
2018
Severe and prolonged myeloid haematopoietic toxicity with myelodysplastic features following alemtuzumab therapy in patients with peripheral T‐cell lymphoproliferative disorders
2005
Rituximab for the treatment of the skin manifestations of dermatomyositis: A report of 3 cases
2006
Management of the primary cutaneous lymphomas
2003
Clinical study of primary cutaneous B‐cell lymphoma using both the European Organization for Research and Treatment of Cancer and World Health Organization classifications
2003
Cutaneous lymphomas: which pathological classification?
2002
Treatment of patients with advanced mycosis fungoides and Sézary syndrome with alemtuzumab
2003
Rituximab in the adjuvant treatment of pemphigus vulgaris: a prospective open-label pilot study in five patients
2007
Graft-versus-lymphoma effect in refractory cutaneous T-cell lymphoma after reduced-intensity HLA-matched sibling allogeneic stem cell transplantation
2004
Extracorporeal photopheresis for the treatment of Sézary syndrome using a novel treatment protocol
2008
Alemtuzumab: effective monotherapy for simultaneous B‐cell chronic lymphocytic leukaemia and Sézary syndrome
2004
Clonal T-helper Lymphocytes and Elevated IL-5 Levels in Episodic Angioedema and Eosinophilia (Gleic h's Syndrome)
2003
Differences in Age and Body Site Distribution of the Histological Subtypes of Basal Cell Carcinoma
1997
Analysis of Dermatologic Events in Vemurafenib-Treated Patients With Melanoma
2013
Lack of durable disease control with chemotherapy for mycosis fungoides and Sézary syndrome: a comparative study of systemic therapy
2014
Conservative management of perforated duodenal ulcer
1988
Long-term outcomes of patients with advanced-stage cutaneous T-cell lymphoma and large cell transformation
2008